Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials

American Journal of Gastroenterology

Volumn 95, Issue 12, 2000, Pages 3393-3398

  Laine, Loren ^a   Fennerty, M Brian ^b   Osato, Michael ^b   Sugg, Jennifer ^b   Suchower, Lisa ^b   Probst, Peter ^b   Levine, Jeffrey G ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Southern California School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ATTAPULGITE; CLARITHROMYCIN; ESOMEPRAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL;

ADULT; AMOXICILLIN; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLIN RESISTANCE; PENICILLINS; PROSPECTIVE STUDIES; PROTEIN SYNTHESIS INHIBITORS; PROTON PUMPS;

EID: 0033634852     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02142-0     Document Type: Article

References (24)

1. A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection
2. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for H. pylori eradication in duodenal ulcer disease: Results of 3 multicenter, double-blind U.S. trials
3. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori
4. Pharmokinetics (PK) and effect of pentagastrin stimulated peak acid output (PAO) of omeprazole (O) and its 2 optical isomers, S-omeprazole/esomeprazole (E) and R-omeprazole (R-O)
5. Pharmacokinetics (PK) and dose-response relationship of esomeprazole (E)
6. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of GERD
7. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial
8. In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials
9. Emergence of clarithromycin-resistant Helicobacter pylori with amoxicillin co-therapy
10. Current U.S. rates of H. pylori antibiotic resistance and factors predicting resistance. Results from ongoing trials at 77 sites
11. Evaluation of risk factors in the surveillance of Helicobacter pylori antimicrobial resistance project (SHARP) in the United States from 1993-1999
12. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis
13. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains
14. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection
15. Highly effective twice daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: Does in vitro metronidazole resistance have any clinical relevance
16. H. pylori eradication with omeprazole, metronidazole, and amoxicillin: The impact of drug dosing and resistance on efficacy - The Homer story
17. U.S. double-blind, controlled trials of omeprazole and amoxicillin for treatment of H. pylori
18. Resistance of Helicobacter pylori to antibiotics
19. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer
20. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: The MACH 2 study
21. Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin
22. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer